View all or


Catalyst shortlisted for Private Equity Awards' UK Corporate Finance Adviser of the Year

Catalyst Corporate Finance has again been shortlisted for the Private Equity Awards’ UK Corporate Finance Adviser of the Year 2017, an award which the firm won in 2016.  

Catalyst advises the shareholders of Raphael Healthcare on its sale to Elysium Healthcare

Catalyst’s Healthcare team has advised the Shareholders of Raphael Healthcare, a provider of specialist mental health services, on its sale to Elysium Healthcare.   

Catalyst advises GI Solutions on their acquisition of the Eclipse Colour Print Group

Catalyst Corporate Finance has advised the shareholders of GI Solutions Group on the acquisition of Eclipse Colour Print, Eclipse 4DM and Direct Link.   

Catalyst advises PS Financials on the sale to IRIS Software Group

Catalyst Corporate Finance has advised the shareholders of PS Financials, the UK’s leading financial management software (FMS) business, on their sale to IRIS Software Group.  

Catalyst leads on Livingbridge investment in Exclaimer

Catalyst Corporate Finance has advised the shareholders of Exclaimer, the largest global provider of email signature software, on the £23 million growth capital investment by Livingbridge.  

Catalyst adds to deal team with three new hires

Catalyst Corporate Finance has expanded its deal making team with the recruitment of William Cooke, Matthew Lee and Jonathan Toh.   

Catalyst looking to exploit opportunities in India

Hot on the heels of Prime Minister Theresa May, Catalyst partners will be heading to India later this week where a number of partners and staff will join fellow members of Catalyst’s international partnership in Mumbai, the location of the second of this year’s Mergers Alliance bi-annual conferences.   

< Previous page Next page >

‘Sustainability’, the key to today’s packaging market

If anyone was still unsure as to the direction the packaging industry is taking, the 2017 Packaging Innovations trade show left little doubt... 

Strong M&A outlook for mid-market pharma

The dynamics highlighted by this year’s Catalyst Pharma Fast 50 show that the sector is prime for further acquisitions and private equity investment... 

Why mid-market pharma is thriving

If there’s one thing that this year’s Pharma Fast 50 emphasises, it is that privately owned pharmaceutical firms in the UK are thriving... 

Optimism on post-Brexit renewables innovation

The sustainability challenges posed by the UK’s forthcoming exit of the EU were a central topic at this year's annual EIC Conference... 

Independent Vetcare – barking up the right tree

The vet market continues to attract plenty of interest. Independent Vetcare is currently being sold in what is rumoured to be a hotly contested auction...